HENRY SCHEIN INCHSIC
ASignal's systematic analysis rates HSIC as Neutral.
Reflects the latest available analysis · analyzed Oct 28, 2026
The case on HSIC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Forward P/E of 14.18x suggests valuation discount relative to current P/E
- Earnings growth of 17.1% indicates strong profitability expansion
- EV/EBITDA of 13.60x below sector average for Healthcare distribution
- Positive MACD histogram indicating potential trend stabilization
- Negative price momentum and trading below SMA50
- Low Reddit mentions (0) indicating weak retail sentiment
- Limited news coverage from only one source (Yahoo)
- Quick ratio of 0.55x signals potential short-term liquidity risk
- RSI near neutral, lacking strong momentum signal
Peers
Clustered with HSIC by analysis-profile similarity.
See the full verdict on HSIC
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes HSIC
Most investors never get a second opinion, let alone several. ASignal runs HSIC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.